Vitrolife AB

Research Vitrolife AB (VITR) on Bullrun: market cap SEK 11.91B, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVITR
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryMedical Devices
• CurrencySEK
• Market capSEK 11.91B
• Dividend yield1.3%
• Financial periodQ1 2026
• RevenueSEK 807.00M
• Net incomeSEK 101.00M
• Free cash flowSEK 172.00M
• Gross margin59.9%

Valuation Snapshot

latest market cap is SEK 11.91B; dividend yield is 1.3%.

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp.

Frequently asked questions

What is Vitrolife AB's market cap?

Vitrolife AB's market capitalization is SEK 11.91B.

Does Vitrolife AB pay a dividend?

Vitrolife AB has a dividend yield of 1.3%.

What does Vitrolife AB do?

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.